Latest News
-

September 2026: This month in Huntington’s disease research
5 min read
September brought progress across the HD research landscape. From brain waves and visual thinking to DNA repeats, nutrition, inclusive care, new technologies, and encouraging SKY-0515 data, we round up a busy month in Huntington’s disease research.
-

Proposed Huntington's disease 'biomarker' is not useful, new study suggests
7 min read
New study shows a blood chemical called '8OHdG' is not a good biomarker for HD. Bad news?
-

Is access to predictive genetic testing for Huntington's disease a problem?
6 min read
Is access to predictive genetic testing for Huntington's disease a problem? A UBC study says it is.
-

HD Therapeutics Conference 2013 Updates: Day 3
9 min read
Final day of our coverage of the Huntington's Disease Therapeutics Conference 2013
-

HD Therapeutics Conference 2013 Updates: Day 2
6 min read
Day 2 of our coverage of the Huntington's Disease Therapeutics Conference
-

Major Roche-Isis deal boosts Huntington's disease gene silencing
5 min read
'ASO' gene silencing drugs for HD boosted by major deal between Isis Pharmaceuticals and Roche
-

HD Therapeutics Conference 2013 Updates: Day 1
5 min read
Day 1 of our coverage of the Huntington's Disease Therapeutics Conference
-

Lost in translation? New insights into the making of the Huntington's disease protein
6 min read
Production of normal-length & extra-long huntingtin is controlled differently. A new way to keep cells healthy in HD?
-

Simple rules for a good night's sleep in Huntington's disease
7 min read
Prof Jenny Morton's simple rules for a good night's sleep in Huntington's disease
-

Is a new technique set to revolutionize Huntington's disease genetic testing?
7 min read
A new genetic testing technique for HD has been reported. What does this mean for people at risk or already tested?
-

No surprises in published results from HART study of Huntexil for Huntington's disease
3 min read
Data from the HART study of Huntexil for HD symptoms now published, but we still need a new, larger trial
